Image

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Join RISE for support in high-risk neuroblastoma research.

Recruiting
17 years and younger
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

Resource Intervention to Support Equity (RISE) is a study to help low-income families with children who have high-risk neuroblastoma, a type of cancer. Neuroblastoma affects young children and involves nerve cells. This study aims to see if a special program called Pediatric RISE, added to the usual care, can improve outcomes for both parents and children.

Participants will be randomly placed into one of two groups: one group will receive the usual care, and the other group will receive the usual care plus Pediatric RISE. Randomly means by chance, like flipping a coin. The study will last about 6 months, and participants will have either in-person or virtual appointments and complete surveys.

  • Length: The study lasts for about 6 months.
  • Visits: Includes in-person or virtual appointments and surveys.
  • Participants: About 84 children from families with low income.

To join, children must be newly diagnosed with high-risk neuroblastoma, and their families must meet certain income guidelines. The study is conducted in several U.S. states.

Print
Study details
    Neuroblastoma
    High-risk Neuroblastoma

NCT06831552

Dana-Farber Cancer Institute

17 October 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.